OM:IMP A SDBMedical Equipment
Assessing Implantica (OM:IMP A SDB) Valuation Following FDA Progress for RefluxStop Device
Implantica (OM:IMP A SDB) saw momentum build this week after the company received positive feedback from the FDA on its RefluxStop device. Recent inspections wrapped up smoothly and set the stage for potential U.S. market entry.
See our latest analysis for Implantica.
That FDA feedback has energized investors, but it comes after an intense year of ups and downs for Implantica. Despite a sharp short-term pullback, such as a 25.9% one-month share price return, the stock's 43.7% year-to-date...